Health experts and pharmaceutical industry leaders yesterday called for policy support and the removal of tariff and non-tariff barriers to boost local production of raw materials for drugs, aiming to ...
The COVID-19 pandemic exposed significant vulnerabilities in global pharmaceutical supply chains, particularly regarding the availability of active pharmaceutical ingredients (APIs)—the essential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results